According to WuXi Biologics's latest financial reports the company's current revenue (TTM) is HK$17.25 B. In 2022 the company made a revenue of HK$17.25 B an increase over the revenue in the year 2021 that were of HK$12.58 B.The revenue is the total amount of income that a company generates by the sale of goods or services. Unlike with the earnings no expenses are subtracted.